News & Announcements

COVID-19 Information

Updates to AIM Clinical Appropriateness Guidelines for Advanced Imaging

The following updates will apply to the AIM Specialty Health* Clinical Appropriateness Guidelines for Radiation Oncology for claims with dates of service on and after March 14, 2021. Please note that there are no restrictive changes in this update.<.p

• Updates to AIM Clinical Appropriateness Guidelines for Advanced Imaging

Flu vaccination reimbursement

• Flu vaccination reimbursement

Racial Trauma Forum Invitation

• Racial Trauma Forum Invitation

Notification regarding inhaled nitric oxide

The purpose of this notification is to inform participating hospitals that the use of inhaled nitric oxide (iNO) during an inpatient stay will be reviewed for medical necessity using our Clinical Utilization Management (UM) Guideline for Inhaled Nitric Oxide, CG-MED-69. iNO is a covered service for eligible members when the use of iNO meets medical necessity criteria.

• Notification regarding inhaled nitric oxide

Talking points for dissolved partnership with Montefiore

The provider collaboration agreement between Empire BlueCross BlueShield HealthPlus (Empire) and Montefiore ACO IPA will dissolve effective January 1, 2020.

• Talking points for dissolved partnership with Montefiore

View all announcements